SPHK1 and breast carcinoma: BzBP is also reported to promote breast cancer metastasis by activating the aryl hydrocarbon receptor and subsequent sphingosine kinase 1 (SPHK1)/sphingosine 1-phosphate (S1P)/sphingosine-1-phosphate receptor 3 (S1PR3) signalling [67].